Maverex assess methods and data used to identify economic evidence (NICE)

The UK National Institute for Health and Care Excellence (NICE) require comprehensive systematic reviews (SRs) of clinical and cost-effectiveness evidence to inform company submissions to the Single Technology Appraisal (STA) process for drug reimbursement.

STA submissions should be up-to-date, well-conducted and follow robust methods. Approaches and resources employed to identify economic evidence varies considerably across submissions.

Maverex conducted a study to assess the search methods and databases used to identify economic evidence within NICE STA submissions in the public domain.

This research was presented at ISPOR 2024.

Contact us today to speak to one of our experts or to discuss how we can support you through the STA submission process.

Find the full slides, and follow us for more content like this, on the Maverex Linkedin pages.

Research link: https://www.linkedin.com/posts/maverex-limited_cost-effectiveness-evidence-in-nice-stas-activity-7226529331420770304-t2eN/